CSIMarket
 


Biodelivery Sciences International Inc   (BDSI)
Other Ticker:  
 
 

BDSI's EPS from Cont. Operations Growth by Quarter and Year

Biodelivery Sciences International Inc 's EPS from Cont. Operations results by quarter and year




BDSI EPS from Cont. Operations (in $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December 0.65 0.10 -0.01 -0.10
III Quarter September 0.07 0.09 0.00 -0.29
II Quarter June 0.09 0.01 -0.13 -0.16
I Quarter March 0.05 0.05 -0.05 -0.18
FY   0.86 0.25 -0.19 -0.73



BDSI EPS from Cont. Operations fourth quarter 2021 Y/Y Growth Comment
Biodelivery Sciences International Inc achieved in the fourth quarter 2021, above Company average EPS from Cont. Operations surge of 546.66% year on year, to $ 0.65 .

Among companies who have reported fourth quarter 2021 results in the Major Pharmaceutical Preparations industry only one Company has achieved higher year on year EPS from Cont. Operations results in the fourth quarter 2021. While Biodelivery Sciences International Inc ' s EPS from Cont. Operations doubling of 546.66% ranks overall at the positon no. 143 in the fourth quarter 2021.




BDSI EPS from Cont. Operations ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December 546.66 % - - -
III Quarter September -22.22 % - - -
II Quarter June 800 % - - -
I Quarter March 0 % - - -
FY   242.66 % - - -

Financial Statements
Biodelivery Sciences International Inc 's fourth quarter 2021 EPS from Cont. Operations $ 0.65 BDSI's Income Statement
Biodelivery Sciences International Inc 's fourth quarter 2020 EPS from Cont. Operations $ 0.10 Quarterly BDSI's Income Statement
New: More BDSI's historic EPS from Cont. Operations Growth >>


BDSI EPS from Cont. Operations (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December 823.8 % 11.11 % - -
III Quarter September -22.22 % 800 % - -
II Quarter June 80 % -80 % - -
I Quarter March -50 % - - -
FY (Year on Year)   242.66 % - - -




EPS from Cont. Operations fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #5
Overall #143

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
800 % 329.63 % -22.22 %
(Jun 30 2021)   (Sep 30 2021)
EPS from Cont. Operations fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #5
Overall #143
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
800 % 329.63 % -22.22 %
(Jun 30 2021)   (Sep 30 2021)

EPS from Cont. Operations by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Biodelivery Sciences International Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
823.8 % 189.97 % -80 %
(Dec 31 2021)  


BDSI's IV. Quarter Q/Q EPS from Cont. Operations Comment
Biodelivery Sciences International Inc achieved in the IV. Quarter 2021 above company average sequential EPS from Cont. Operations doubling of 823.8%, to $ 0.65 , from $0.07 in the third quarter.
Biodelivery Sciences International Inc is going from strength to strength, not only reporting better then regular growth, and additionally accelerating rate, Laura Dupont, Healthcare sector contributor situated in Antwerpen said.

Within Major Pharmaceutical Preparations industry Biodelivery Sciences International Inc achieved highest sequential EPS from Cont. Operations growth. While Biodelivery Sciences International Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is 56.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #0
Healthcare Sector #3
Overall #56
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #0
Healthcare Sector #3
Overall #56
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
823.8 % 189.97 % -80 %
(Dec 31 2021)  


BDSI's IV. Quarter Q/Q EPS from Cont. Operations Comment
Biodelivery Sciences International Inc achieved in the IV. Quarter 2021 above company average sequential EPS from Cont. Operations doubling of 823.8%, to $ 0.65 , from $0.07 in the third quarter.
Major Pharmaceutical Preparations company is going from strength to strength, not just claiming above average growth, and also improving pace.

Within Major Pharmaceutical Preparations industry Biodelivery Sciences International Inc achieved highest sequential EPS from Cont. Operations growth. While Biodelivery Sciences International Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is 56.


Biodelivery Sciences International Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
Cumulative EPS from Cont. Operations 12 Months Ending $ 0.86 $ 0.31 $ 0.33 $ 0.25 $ 0.25
Y / Y EPS from Cont. Operations Growth (TTM) 241.4 % 118.82 % - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # 169 # 402 # 0 # 0 # 0
Seqeuential EPS from Cont. Operations Change (TTM) 175.52 % -6.04 % 31.88 % 0 % 76.59 %
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # 596 # 1710 # 537 # 1142 # 598




Cumulative EPS from Cont. Operations growth Comment
With 241.4% annual EPS from Cont. Operations growth, Biodelivery Sciences International Inc would report a record annual EPS from Cont. Operations surge if the fiscal year would end on Dec 31 2021.

Among companies within the Healthcare sector 11 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While Total ranking has impoved so far to 169, from total ranking in previous quarter at 402.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
241.4 %
-349.03 %
-1083.16 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 10
Healthcare Sector # 12
Overall # 169

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
241.4 %
180.11 %
118.82 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 31
S&P 500 # 596
Cumulative EPS from Cont. Operations growth Comment
With 241.4% annual EPS from Cont. Operations growth, Biodelivery Sciences International Inc would report a record annual EPS from Cont. Operations surge if the fiscal year would end on Dec 31 2021.

Among companies within the Healthcare sector 11 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While Total ranking has impoved so far to 169, from total ranking in previous quarter at 402.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
241.4 %
-349.03 %
-1083.16 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 10
Healthcare Sector # 12
Overall # 169

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
241.4 %
180.11 %
118.82 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 31
S&P 500 # 596




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
BDSI's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for BDSI's Competitors
EPS from Cont. Operations Growth for Biodelivery Sciences International Inc 's Suppliers
EPS from Cont. Operations Growth for BDSI's Customers

You may also want to know
BDSI's Annual Growth Rates BDSI's Profitability Ratios BDSI's Asset Turnover Ratio BDSI's Dividend Growth
BDSI's Roe BDSI's Valuation Ratios BDSI's Financial Strength Ratios BDSI's Dividend Payout Ratio
BDSI's Roa BDSI's Inventory Turnover Ratio BDSI's Growth Rates BDSI's Dividend Comparisons



Companies with similar EPS from Cont. Operations surge for the quarter ending Dec 31 2021 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Dec 31 2021
Biocept Inc 787.86%$ 787.861 
Biodelivery Sciences International Inc 540.74%$ 540.736 
Integer Holdings Corporation513.45%$ 513.453 
Iradimed Corporation503.50%$ 503.501 
Pfizer Inc465.27%$ 465.274 
Sensus Healthcare Inc 420.64%$ 420.636 
Iteos Therapeutics Inc 389.85%$ 389.847 
Zomedica Corp 352.17%$ 352.172 
Harmony Biosciences Holdings inc 345.10%$ 345.101 
Atea Pharmaceuticals Inc 337.04%$ 337.042 
Siga Technologies Inc280.28%$ 280.279 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com